feed,title,long_url,short_url
Benzinga,Lung-Disease Focused AN2 Therapeutics Files Plans For NASDAQ Debut,https://benzinga.com/general/biotech/22/03/26023288/lung-disease-focused-an2-therapeutics-files-plans-for-nasdaq-debut,https://bit.ly/3tDtIP3
Benzinga,"Evolent Health 'Notification Award' Removes $82M Overhang, Notes Piper Sandler",https://benzinga.com/news/22/03/26023264/evolent-health-notification-award-removes-82m-overhang-notes-piper-sandler,https://bit.ly/3hLZ9RV
